Pro Medical Baltic - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,310,952 | 1,007,767 | 1,122,219 | 1,732,100 | 2,062,915 | 2,833,391 | 2,099,876 | 1,700,433 |
| Profit before tax | -37,085 | -89,078 | 42,078 | 557,120 | 548,753 | 781,888 | 566,822 | 35,011 |
| Net profit | -37,840 | -114,240 | 35,525 | 503,679 | 461,682 | 649,032 | 476,254 | 26,617 |
| Equity | 1,280,146 | 1,024,730 | 865,755 | 1,049,797 | 1,567,951 | 1,616,983 | 1,443,237 | 719,854 |
| Liabilities | 62,025 | 281,113 | 89,883 | 192,399 | 377,986 | 567,849 | 190,276 | 87,989 |
| Non-current assets | 261,992 | 46,758 | 71,567 | 49,296 | 38,681 | 26,060 | 68,890 | 112,912 |
| Current assets | 1,077,088 | 1,256,278 | 880,561 | 1,191,936 | 1,906,117 | 2,158,007 | 1,563,278 | 698,452 |
| Total assets | 1,339,080 | 1,303,036 | 952,128 | 1,241,232 | 1,944,798 | 2,184,067 | 1,632,168 | 811,364 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 264,406 | 236,313 | 203,011 |
| Social insurance contributions | - | - | - | - | - | 47,504 | 73,183 | 66,800 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +50.6% | -23.1% | +11.4% | +54.3% | +19.1% | +37.3% | -25.9% | -19.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.8% | -8.8% | 3.7% | 40.6% | 23.7% | 29.7% | 29.2% | 3.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -3.0% | -11.1% | 4.1% | 48.0% | 29.4% | 40.1% | 33.0% | 3.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -2.9% | -11.3% | 3.2% | 29.1% | 22.4% | 22.9% | 22.7% | 1.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -2.8% | -8.8% | 3.7% | 32.2% | 26.6% | 27.6% | 27.0% | 2.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.3 | 0.1 | 0.2 | 0.2 | 0.4 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 436,984 | 186,048 | 187,037 | 288,683 | 317,372 | 435,906 | 299,982 | 240,062 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Pro Medical Baltic - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-19 | 2026-08-19 | 149.26 |
| 2024-12-17 | 2024-12-20 | 85.17 |
| 2022-09-16 | 2022-09-29 | 0.86 |
| 2022-08-23 | 2022-08-30 | 0.86 |
| 2022-04-25 | 2022-04-28 | 0.34 |
| 2022-02-17 | 2022-02-20 | 14.47 |
| 2022-01-18 | 2022-01-19 | 918.80 |
Pro Medical Baltic - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-28 | 2025-04-08 | 0.07 |
| 2025-03-19 | 2025-03-24 | 0.07 |
| 2025-02-28 | 2025-03-18 | 0.23 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Pro Medical Baltic, UAB (code 302103589) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of EUR 1.70M and net profit of EUR 26.6K, compared with EUR 2.10M revenue and EUR 476.3K net profit in 2024 and EUR 2.83M revenue and EUR 649.0K net profit in 2023. This shows a clear two-year decline in both sales and profitability. Revenue fell by 19.0% year on year in 2025 and by 40.0% over two years, while the net profit margin narrowed to 1.6% from 22.7% in 2024 and 22.9% in 2023. At year-end 2025, total assets stood at EUR 811.4K, equity at EUR 719.9K and liabilities at EUR 88.0K. The equity ratio was 88.7% and debt-to-equity 0.12, indicating a strong capital position. Asset turnover was 2.10x. Revenue per employee was EUR 242.9K and profit per employee EUR 3.8K in 2025.